Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zuo-Lin Li

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Advances in Experimental Medicine and Biology|August 11, 2019
Hypoxia and Renal Tubulointerstitial FibrosisZuo-Lin Li, Bi-Cheng Liu
Kidney Diseases (Basel, Switzerland)|April 21, 2020
Treatment of Renal Anemia with Roxadustat: Advantages and AchievementZuo-Lin Li, Yan Tu, Bi-Cheng Liu
Renal Failure|January 27, 2025
Endothelial injury is one of the risk factors for the progression of vascular calcification in patients receiving maintenance dialysisDan-Dan Yao, Xiao-Wei Yan, Yan Zhou, et al.
Cell Biochemistry and Function|December 31, 2019
MicroRNA26a inhibits cisplatin-induced renal tubular epithelial cells apoptosis through suppressing the expression of transient receptor potential channel 6 mediated dynamin-related protein 1Yan Yang, Zuo-Lin Li, Feng-Mei Wang, et al.
Antioxidants & Redox Signaling|January 19, 2022
Disturbance of Hypoxia Response and Its Implications in Kidney DiseasesZuo-Lin Li, Bin Wang, Yi Wen, et al.
Ebiomedicine|March 15, 2022
Hypoxia and chronic kidney diseaseBin Wang, Zuo-Lin Li, Yi-Lin Zhang, et al.
Heliyon|April 15, 2024
Renal cell carcinoma in an adult-onset ESRD patient with nephronophthisis harboring <i>NPHP3</i> deletion: A case reportZuo-Lin Li, Feng-Mei Wang, Yi Wen, et al.
Ebiomedicine|August 23, 2024
Renal tubular epithelial cells response to injury in acute kidney injuryZuo-Lin Li, Xin-Yan Li, Yan Zhou, et al.
Journal of Pharmacological Sciences|May 25, 2020
Dopamine D1 receptor agonist A68930 attenuates acute kidney injury by inhibiting NLRP3 inflammasome activationJing-Yuan Cao, Le-Ting Zhou, Zuo-Lin Li, et al.
Journal of Cellular and Molecular Medicine|October 31, 2017
Therapeutic application of extracellular vesicles in kidney disease: promises and challengesLin-Li Lv, Wei-Jun Wu, Ye Feng, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Advances in Experimental Medicine and Biology|August 11, 2019
Hypoxia and Renal Tubulointerstitial FibrosisZuo-Lin Li, Bi-Cheng Liu
Kidney Diseases (Basel, Switzerland)|April 21, 2020
Treatment of Renal Anemia with Roxadustat: Advantages and AchievementZuo-Lin Li, Yan Tu, Bi-Cheng Liu
Renal Failure|January 27, 2025
Endothelial injury is one of the risk factors for the progression of vascular calcification in patients receiving maintenance dialysisDan-Dan Yao, Xiao-Wei Yan, Yan Zhou, et al.
Cell Biochemistry and Function|December 31, 2019
MicroRNA26a inhibits cisplatin-induced renal tubular epithelial cells apoptosis through suppressing the expression of transient receptor potential channel 6 mediated dynamin-related protein 1Yan Yang, Zuo-Lin Li, Feng-Mei Wang, et al.
Antioxidants & Redox Signaling|January 19, 2022
Disturbance of Hypoxia Response and Its Implications in Kidney DiseasesZuo-Lin Li, Bin Wang, Yi Wen, et al.
Ebiomedicine|March 15, 2022
Hypoxia and chronic kidney diseaseBin Wang, Zuo-Lin Li, Yi-Lin Zhang, et al.
Heliyon|April 15, 2024
Renal cell carcinoma in an adult-onset ESRD patient with nephronophthisis harboring <i>NPHP3</i> deletion: A case reportZuo-Lin Li, Feng-Mei Wang, Yi Wen, et al.
Ebiomedicine|August 23, 2024
Renal tubular epithelial cells response to injury in acute kidney injuryZuo-Lin Li, Xin-Yan Li, Yan Zhou, et al.
Journal of Pharmacological Sciences|May 25, 2020
Dopamine D1 receptor agonist A68930 attenuates acute kidney injury by inhibiting NLRP3 inflammasome activationJing-Yuan Cao, Le-Ting Zhou, Zuo-Lin Li, et al.
Journal of Cellular and Molecular Medicine|October 31, 2017
Therapeutic application of extracellular vesicles in kidney disease: promises and challengesLin-Li Lv, Wei-Jun Wu, Ye Feng, et al.
Pageof 7